Baxter International Stock Price and Value Analysis

Should you buy Baxter International stock? (NYSE:BAX). Let's see how it does in our automated value investing analysis system.

  • This company has stable growth.
  • This company is very stable.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company is not making money.

BAX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Baxter International's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for BAX
Free Cash Flow trendline for Baxter International

Inside the BAX Numbers

BAX Price
(Baxter International stock price per share)
[?] PE Ratio versus Sector 167% higher than other Healthcare stocks
[?] PE Ratio versus Industry 124% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 9.37%
[?] Free Cash Flow Jitter 20%
[?] Dividend Yield 1%

Is Baxter International Stock on Sale?

Based on our analysis, we believe that you should not buy Baxter International right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy BAX Stock?

Does Baxter International have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.